QOL Medical and Their CEO Settle for $4.7 Million Over Alleged Kickback Scheme Involving Genetic Testing and Drug Claims Read more
Updates from FDA’s Office of Prescription Drug Promotion: Standards for Direct-to-Consumer Advertising Read more